펨토바이오메드 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 이상현, was filed 06 Nov 2025.
펨토바이오메드: what insiders have been doing
Every trade that managers of 펨토바이오메드 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for 펨토바이오메드. The previous disclosure was published on 6 November 2025.
The full history, which starts in 2021, counts 8 purchases against 15 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleFinancial data
· cache
- 24,654 sharesKRXDART:20251106000123Canonical exit: 3 Feb 2026 (T+90)
- 20,666 sharesShareKRXDART:20251106000126Canonical exit: 4 Feb 2026 (T+90)
- 1,273,535 sharesShareKRXDART:20250609000018Canonical exit: 7 Sept 2025 (T+90)
- 172 sharesShareKRXDART:20250609000020Canonical exit: 7 Sept 2025 (T+90)
- 8,300 sharesShareKRXDART:20250609000135Canonical exit: 7 Sept 2025 (T+90)
- 201,021 sharesKRXDART:20250107000182
- 201,021 sharesKRXDART:20240508000045
- 201,021 sharesKRXDART:20230921000357
- 201,021 sharesKRXDART:20230913000367
- 201,021 sharesKRXDART:20230911000289
- 201,021 sharesKRXDART:20230906000121
- 201,021 sharesKRXDART:20230601000206
- 201,021 sharesKRXDART:20230414002135
- 201,021 sharesKRXDART:20221216000472
- 201,021 sharesKRXDART:20221216000444
- 201,021 sharesKRXDART:20221216000413
- 201,021 sharesKRXDART:20220414000849
- ShareKRXDART:20220414000863Canonical exit: 13 Jul 2022 (T+90)
- 201,021 sharesKRXDART:20210826000160
- 201,021 sharesKRXDART:20210805000086
- ShareKRXDART:20210805000090Canonical exit: 3 Nov 2021 (T+90)
- ShareKRXDART:20210615000418Canonical exit: 13 Sept 2021 (T+90)
- 201,021 sharesKRXDART:20210615000422
- ●Executives0DART
- ●Executives0DART
25 of 27 declarations
About 펨토바이오메드
펨토바이오메드 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.
